[1] |
YANG L, ZHENG R, WANG N, et al. Incidence and mortality of stomach cancer in China,2014[J]. Chin J Cancer Res, 2018, 30(3):291-298.
DOI
URL
|
[2] |
TOYA Y, NAKAMURA S, URUSHIKUBO J, et al. Diffuse cystic malformation with early gastric cancer[J]. J Gastrointest Surg, 2018, 22(6):1130-1131.
DOI
URL
|
[3] |
ZUO X, LI B, ZHU C, et al. Stoichiogenomics reveal oxygen usage bias,key proteins and pathways associated with stomach cancer[J]. Sci Rep, 2019, 9(1):11344.
DOI
URL
|
[4] |
MITRA R, SUN J, ZHAO Z. MicroRNA regulation in cancer:one arm or two arms?[J]. Int J Cancer, 2015, 137(6):1516-1518.
DOI
URL
|
[5] |
HAO N B, HE Y F, LI X Q, et al. The role of miRNA and lncRNA in gastric cancer[J]. Oncotarget, 2017, 8(46):81572-81582.
DOI
URL
|
[6] |
KOENIG A B, BARAJAS J M, GUERRERO M J, et al. A comprehensive analysis of argonaute-clip data identifies novel,conserved and species-specific targets of mir-21 in human liver and hepatocellular carcinoma[J]. Int J Mol Sci, 2018, 19(3):851.
DOI
URL
|
[7] |
UOZAKI H, MORITA S, KUMAGAI A, et al. Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer[J]. Histopathology, 2014, 65(6):775-783.
DOI
URL
|
[8] |
WANG H, TAN Z, HU H, et al. MicroRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1[J]. BMC Cancer, 2019, 19(1):738.
DOI
URL
|
[9] |
WU H, HUANG M, CAO P, et al. MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation[J]. Cancer Biol Ther, 2012, 13(5):281-288.
DOI
URL
|
[10] |
WANG Q, ZHANG H, SHEN X, et al. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer[J]. Ann Clin Biochem, 2017, 54(1):76-85.
DOI
URL
|
[11] |
ZHANG X, GAO F, ZHOU L, et al. UCA1 regulates the growth and metastasis of pancreatic cancer by sponging mir-135a[J]. Oncol Res, 2017, 25(9):1529-1541.
DOI
URL
|
[12] |
陕飞, 李子禹, 张连海, 等. 国际抗癌联盟及美国肿瘤联合会胃癌TNM分期系统(第8版)简介及解读[J]. 中国实用外科杂志, 2017, 37(1):15-17.
|
[13] |
ALEEBRAHIM-DEHKORDY E, NASRI H, BARADARAN A, et al. Medicinal plants,effective plant compounds(compositions) and their effects on stomach cancer[J]. Int J Prev Med, 2017, 8:96.
|
[14] |
YI D, WANG R, SHI X, et al. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression[J]. Oncol Rep, 2020, 43(5):1375-1386.
|
[15] |
ZHANG X, NIE Y, LI X, et al. MicroRNA-181a functions as an oncomir in gastric cancer by targeting the tumour suppressor gene ATM[J]. Pathol Oncol Res, 2014, 20(2):381-389.
DOI
URL
|
[16] |
ZENG J F, MA X Q, WANG L P, et al. MicroRNA-145 exerts tumor-suppressive and chemo-resistance lowering effects by targeting CD44 in gastric cancer[J]. World J Gastroenterol, 2017, 23(13):2337-2345.
DOI
URL
|
[17] |
CHAN S H, WU C W, LI A F, et al. MiR-21 microRNA expression in human gastric carcinomas and its clinical association[J]. Anticancer Res, 2008, 28(2A):907-911.
|
[18] |
BAO L, YAN Y, XU C, et al. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways[J]. Cancer Lett, 2013, 337(2):226-236.
DOI
URL
|
[19] |
MOTOYAMA K, INOUE H, MIMORI K, et al. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer[J]. Int J Oncol, 2010, 36(5):1089-1095.
|
[20] |
ZHANG C, CHEN X, CHEN X, et al. MiR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1[J]. Onco Targets Ther, 2016, 9:3555-3563.
|
[21] |
ZHANG Z, REN L, ZHAO Q, et al. TRPC1 exacerbate metastasis in gastric cancer via ciRS-7/miR-135a-5p/TRPC1 axis[J]. Biochem Biophys Res Commun, 2020, 529(1):85-90.
DOI
URL
|